| Original language | English (US) |
|---|---|
| Title of host publication | Personalized Management of Lung Cancer |
| Publisher | Future Medicine Ltd. |
| Pages | 193-212 |
| Number of pages | 20 |
| ISBN (Electronic) | 9781780842165 |
| ISBN (Print) | 9781780842189 |
| DOIs | |
| State | Published - Aug 1 2013 |
ASJC Scopus subject areas
- Medicine(all)
Cite this
Bi, N., & Kong, F. M. (2013). Considerations of practice guidelines and recommendations. In Personalized Management of Lung Cancer (pp. 193-212). Future Medicine Ltd.. https://doi.org/10.2217/EBO.13.197
Considerations of practice guidelines and recommendations. / Bi, Nan; Kong, Feng Ming.
Personalized Management of Lung Cancer. Future Medicine Ltd., 2013. p. 193-212.Research output: Chapter in Book/Report/Conference proceeding › Chapter
Bi, N & Kong, FM 2013, Considerations of practice guidelines and recommendations. in Personalized Management of Lung Cancer. Future Medicine Ltd., pp. 193-212. https://doi.org/10.2217/EBO.13.197
Bi N, Kong FM. Considerations of practice guidelines and recommendations. In Personalized Management of Lung Cancer. Future Medicine Ltd. 2013. p. 193-212 https://doi.org/10.2217/EBO.13.197
@inbook{d6ea46a0a0ce41a5b1385ac9d1f12cdf,
title = "Considerations of practice guidelines and recommendations",
author = "Nan Bi and Kong, {Feng Ming}",
year = "2013",
month = "8",
day = "1",
doi = "10.2217/EBO.13.197",
language = "English (US)",
isbn = "9781780842189",
pages = "193--212",
booktitle = "Personalized Management of Lung Cancer",
publisher = "Future Medicine Ltd.",
}
TY - CHAP
T1 - Considerations of practice guidelines and recommendations
AU - Bi, Nan
AU - Kong, Feng Ming
PY - 2013/8/1
Y1 - 2013/8/1
UR - http://www.scopus.com/inward/record.url?scp=84959246694&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84959246694&partnerID=8YFLogxK
U2 - 10.2217/EBO.13.197
DO - 10.2217/EBO.13.197
M3 - Chapter
AN - SCOPUS:84959246694
SN - 9781780842189
SP - 193
EP - 212
BT - Personalized Management of Lung Cancer
PB - Future Medicine Ltd.
ER -